Vibrio vulnificus is a marine bacterium known to cause severe infections, particularly in individuals with compromised immune systems or pre-existing conditions like liver disease and iron overload . The ability of V. vulnificus to acquire iron from its host is linked to its virulence . It can utilize iron sources such as hemoglobin and heme .
VV2132 is a protein that belongs to the UPF0208 family, which stands for "Unknown Protein Function" . Proteins in this family have a conserved amino acid sequence but their exact function is not yet known.
| Property | Value |
|---|---|
| Chemical Name | Recombinant Vibrio vulnificus UPF0208 membrane protein VV2132 (VV2132) |
| CBNumber | CB015639855 |
| Molecular Weight | 0 |
| MDL Number | |
| MOL File | Mol file |
VV2132 is a membrane protein, which means it is located in the cell membrane of V. vulnificus . More specifically, it is an outer membrane protein . Outer membrane proteins are important for the interaction of bacteria with their environment. They can be involved in nutrient transport, cell adhesion, and defense against harmful substances .
While the specific function of VV2132 is currently unknown, its nature as an outer membrane protein suggests a role in the virulence of V. vulnificus. Research has shown that outer membrane proteins in bacteria can directly influence antimicrobial resistance mechanisms and virulence .
One well-characterized outer membrane protein of Vibrio species is OmpU, which contributes to antimicrobial peptide resistance and is required for virulence in oysters .
The expression of some outer membrane proteins in V. vulnificus is regulated by iron . For example, the expression of HupA, a heme receptor, is strongly regulated by iron, with transcription being repressed under high-iron conditions . A fur mutant of V. vulnificus constitutively expresses certain iron-regulated outer membrane proteins .
A study on V. vulnificus Vv180806 identified a large number of acetylated proteins, suggesting a significant role for acetylation in this bacterium . Acetylation is a post-translational modification that can affect protein function . The study identified 6,626 high-confidence acetylation sites on 1,924 proteins, representing over 40% of the total proteins in the strain .
KEGG: vvy:VV2132
When working with lyophilized VV2132 protein, several critical experimental considerations must be addressed to maintain protein integrity:
Reconstitution Protocol:
Briefly centrifuge the vial prior to opening to bring contents to the bottom
Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL
For long-term storage, add glycerol to a final concentration of 5-50% (50% is recommended for optimal stability)
Storage Conditions:
Store reconstituted protein at -20°C/-80°C for extended storage
Working aliquots can be maintained at 4°C for up to one week
Avoid repeated freeze-thaw cycles as they significantly compromise protein stability
Buffer Composition:
Tris-based buffer systems with pH 8.0 maintain VV2132 stability
The addition of 6% trehalose acts as a cryoprotectant for preserving protein structure during freeze-thaw processes
These considerations are essential for researchers to obtain reliable and reproducible results in downstream applications. Proper handling ensures that the structural and functional integrity of VV2132 is preserved throughout experimental procedures.
Validating the structural integrity of purified VV2132 is critical before proceeding with functional studies. A comprehensive validation approach should include:
Purity Assessment:
SDS-PAGE analysis to confirm >90% purity as a minimum acceptance criterion
Western blot verification using anti-His antibodies (for His-tagged variants) to confirm identity
Biophysical Characterization:
Circular Dichroism (CD) spectroscopy to evaluate secondary structure elements characteristic of membrane proteins
Dynamic Light Scattering (DLS) to assess protein homogeneity and detect potential aggregation
Thermal shift assays to determine protein stability and optimal buffer conditions
Functional Validation:
Lipid binding assays to confirm proper membrane association properties
Pilot interaction studies if potential binding partners have been identified
Structural Analysis:
Negative stain electron microscopy for preliminary structural assessment and homogeneity evaluation
Size Exclusion Chromatography to verify the oligomeric state of the protein
Implementing these validation steps ensures that subsequent functional studies are performed with structurally intact protein, significantly increasing the reliability of experimental outcomes and interpretations. Particular attention should be paid to confirming membrane protein characteristics, as improper folding can drastically affect functional properties.
When designing experiments to investigate VV2132 function, researchers should implement a systematic approach following established experimental design principles:
Variable Definition:
Independent variables: Protein concentration, buffer conditions, temperature, pH, interaction partners
Dependent variables: Membrane binding, structural stability, protein-protein interactions, cellular effects
Control variables: Must be rigorously maintained to ensure experimental validity
Experimental Design Types:
Pre-experimental designs:
Quasi-experimental designs:
True experimental designs:
Posttest-only control group: Compare systems with and without VV2132
Pretest-posttest control group: Measure effects before and after VV2132 introduction while maintaining control groups
Solomon four-group design: Most comprehensive approach incorporating all permutations of control and experimental conditions
Methodological Framework:
Define a specific, testable hypothesis about VV2132 function
Select appropriate experimental and control groups
Determine precise measurement protocols for dependent variables
Implement controls for confounding variables
Establish statistical analysis approach before experimentation
This structured approach to experimental design will help researchers systematically investigate the unknown function of VV2132, minimizing bias and maximizing the reliability of findings.
Investigating VV2132 variation across Vibrio vulnificus strains requires a robust genetic study design that builds on successful approaches used for other V. vulnificus virulence factors:
Sampling Strategy:
Include diverse isolates representing:
Clinical sources (patient isolates)
Environmental sources (seawater, sediment, shellfish)
Geographic diversity
Temporal diversity (historical and recent isolates)
Aim for at least 40 strains for meaningful variation analysis, similar to successful studies of MARTX Vv toxin variants
Sequencing Methodology:
PCR amplification of the entire VV2132 gene using conserved flanking primers
Bidirectional Sanger sequencing for accurate variant identification
Whole genome sequencing for broader genomic context when possible
Bioinformatic Analysis:
Multiple sequence alignment to identify conserved and variable regions
Phylogenetic analysis to establish evolutionary relationships between variants
Recombination detection algorithms to identify potential gene exchange events
Selection pressure analysis (dN/dS ratios) to identify regions under selection
Variant Characterization:
Clone identified variants for recombinant expression
Perform comparative biochemical characterization
Correlate variants with strain characteristics (virulence, environmental adaptation)
Functional Validation:
Generate isogenic strains expressing different VV2132 variants
Compare phenotypes related to membrane function
Assess impact on environmental fitness and potential virulence
This approach parallels successful studies of rtxA1 gene variants in V. vulnificus, where genetic recombination led to toxins with different effector domain arrangements and altered virulence potential . Similar mechanisms may drive VV2132 evolution, potentially affecting membrane properties or interactions with host factors.
When investigating the potential role of VV2132 in Vibrio vulnificus pathogenesis, implementing rigorous control measures is essential to ensure reliable and interpretable results:
Genetic Controls:
Complementation Controls:
Include wild-type complementation of VV2132 deletion mutants
Engineer point mutations in functional domains for structure-function analysis
Create chimeric proteins with domains from related proteins to identify functional regions
Multiple Strain Background Controls:
Experimental Controls:
Positive Controls:
Include experiments with known virulence factors (MARTX, VvhA) for comparison
Use established pathogenesis models with predictable outcomes
Negative Controls:
Include knockouts of non-virulence associated genes
Use non-pathogenic Vibrio species as comparative models
Vehicle Controls:
Include buffer-only and irrelevant protein controls in cell culture experiments
Employ mock infection controls in animal models
Methodological Controls:
Dose-Response Assessment:
Test multiple concentrations/doses to establish threshold effects
Evaluate time-course responses to distinguish primary from secondary effects
Multiple Readout Systems:
Combine different virulence assessment methodologies
Employ both in vitro cell culture and in vivo animal models
Use multiple cell types to avoid cell-specific artifacts
Environment Variation:
Test under different conditions mimicking host environments (temperature, pH, iron availability)
Include conditions that activate different virulence programs
These comprehensive control measures will help distinguish specific VV2132 effects from general bacterial responses or experimental artifacts, providing more reliable insights into any pathogenesis-related functions. This approach has been successfully applied to characterize other Vibrio vulnificus virulence factors like MARTX toxins and VvhA hemolysin .
Structural characterization of membrane proteins like VV2132 presents unique challenges that require specialized approaches. The following methodological framework optimizes structural biology studies of VV2132:
X-ray Crystallography Optimization:
Construct Engineering:
Design truncation variants removing flexible regions
Create fusion proteins with crystallization chaperones (T4 lysozyme, BRIL)
Introduce surface mutations to promote crystal contacts
Crystallization Strategies:
Implement lipidic cubic phase (LCP) crystallization
Screen detergent:lipid ratios systematically
Utilize bicelles or nanodiscs for near-native membrane environment
Cryo-Electron Microscopy Approaches:
Sample Preparation:
Reconstitute in nanodiscs with defined lipid composition
Optimize grid preparation with detergent screening
Apply GraFix technique to stabilize protein complexes
Data Collection Strategy:
Implement phase plates for improved contrast
Collect tilt series to address preferred orientation issues
Utilize energy filters to enhance signal-to-noise ratio
Solution NMR Techniques:
Isotope Labeling:
Express with selective labeling schemes (15N, 13C, 2H)
Implement amino acid-specific labeling for assignment
Use segmental labeling for larger constructs
Membrane Mimetics:
Optimize detergent micelles for spectral quality
Test bicelles of varying q-factors
Employ nanodiscs with different MSP constructs
Integrative Approaches:
Computational Integration:
Build homology models based on UPF0208 family members
Refine with molecular dynamics simulations
Validate with experimental constraints
Hybrid Methods:
Combine low-resolution EM with high-resolution X-ray data
Integrate mass spectrometry data (HDX-MS, cross-linking)
Incorporate SAXS/SANS for solution conformation validation
VV2132's relatively small size (150 amino acids) makes it amenable to multiple structural approaches. The determined structure would provide critical insights into this poorly characterized membrane protein family and potentially reveal functional mechanisms relevant to Vibrio vulnificus biology.
Recombinant VV2132 offers valuable opportunities for immunological investigations of Vibrio vulnificus, drawing on successful approaches used with other V. vulnificus proteins like VvhA:
Antibody Development:
Polyclonal Antibody Production:
Immunize animal models with purified recombinant VV2132
Characterize antibody specificity via Western blot and ELISA
Apply for detection in bacterial lysates and during infection conditions
Monoclonal Antibody Generation:
Screen hybridoma clones against different regions of VV2132
Select antibodies recognizing native conformations
Develop assays requiring high specificity detection
Immunological Research Applications:
Expression Analysis:
Track VV2132 expression under different environmental conditions
Investigate regulation during host-pathogen interactions
Compare expression across different V. vulnificus strains
Localization Studies:
Determine subcellular localization via immunofluorescence
Examine surface accessibility through flow cytometry
Characterize membrane domain association
Host Response Characterization:
Assess ability to stimulate innate immune responses
Evaluate potential for adaptive immune recognition
Compare with known immunogenic V. vulnificus proteins
Vaccine Research Potential:
Immunization Studies:
Evaluate VV2132 as a potential vaccine candidate
Characterize immune responses (antibody titers, T-cell activation)
Assess protection in challenge models
Correlative Protection Studies:
Determine if anti-VV2132 antibodies correlate with protection
Analyze neutralizing capacity against bacterial functions
Compare with protection conferred by other V. vulnificus antigens
This approach draws on successful immunological characterization of VvhA, where recombinant leukocidin domain immunization elicited protective responses with mixed Th1/Th2 immune activation . If VV2132 plays a role in pathogenesis or represents a conserved antigen, immunological methods may reveal its function and potential as a therapeutic target.
Comparative genomics provides powerful tools to understand the evolutionary context and potential functional significance of VV2132. The following methodological framework should be implemented:
Sequence-Based Analysis:
Ortholog Identification:
BLAST/HMMER searches across sequenced Vibrio genomes
Reciprocal best hit analysis to confirm orthology
Construction of comprehensive ortholog database
Phylogenetic Analysis:
Multiple sequence alignment of all identified orthologs
Maximum likelihood tree construction
Reconciliation with species phylogeny to identify gene duplication/loss events
Selection Analysis:
Calculate dN/dS ratios across aligned sequences
Identify sites under positive or purifying selection
Compare selection patterns with known functional domains
Genomic Context Analysis:
Synteny Mapping:
Examine conservation of genes flanking VV2132
Identify operonic structures and potential co-regulated genes
Compare genomic organization across Vibrio species
Mobile Element Association:
Screen for nearby insertion sequences, transposons, or phage elements
Assess potential for horizontal gene transfer
Examine GC content for evidence of foreign origin
Regulatory Element Analysis:
Identify conserved promoter elements
Map potential transcription factor binding sites
Compare with regulons of known virulence factors
Functional Association Mapping:
Co-expression Network Analysis:
Integrate available transcriptomic data across conditions
Identify genes with similar expression patterns
Construct co-expression networks to predict function
Protein Domain Architecture:
Compare domain organization with related proteins
Identify conserved functional motifs
Map evolutionary events affecting domain composition
Strain Phenotype Correlation:
This comprehensive approach will reveal whether VV2132 follows evolutionary patterns similar to housekeeping genes (high conservation) or virulence factors (higher variability, evidence of horizontal transfer or recombination, as seen with rtxA1) . The findings will provide critical context for functional studies and potential role in Vibrio vulnificus biology.
Selecting the optimal expression system for VV2132 is critical for obtaining properly folded, functional protein. The following methodological considerations should guide system selection and optimization:
Prokaryotic Expression Systems:
E. coli-Based Expression:
Strain Selection:
Vector Optimization:
pET series with T7 promoter for high-level expression
pBAD with arabinose-inducible promoter for titratable expression
Codon optimization for enhanced translation efficiency
Fusion Strategies:
Expression Condition Optimization:
| Parameter | Range to Test | Monitoring Method |
|---|---|---|
| Induction OD₆₀₀ | 0.4-1.0 | Growth curves |
| Inducer Concentration | 0.01-1.0 mM IPTG | SDS-PAGE |
| Post-induction Temperature | 16-30°C | Western blot |
| Expression Duration | 4-24 hours | Functional assays |
| Media Composition | LB, TB, auto-induction | Yield quantification |
Eukaryotic Expression Systems (for challenging cases):
Yeast Systems:
Pichia pastoris: Methylotrophic yeast with strong inducible promoters
Saccharomyces cerevisiae: Well-established genetics for membrane proteins
Insect Cell Systems:
Baculovirus expression vector system (BEVS)
Stable Drosophila S2 cell lines
Cell-Free Expression:
E. coli extract supplemented with detergents or lipids
Wheat germ extract for eukaryotic-like folding
For VV2132 specifically, E. coli expression systems have demonstrated success, with the protein successfully produced with an N-terminal His tag . Lower post-induction temperatures (16-25°C) and extended expression times often improve membrane protein folding and yield. Systematic optimization of expression conditions through Design of Experiments (DoE) approaches can further enhance product quality and quantity.
Resolving conflicting data in VV2132 functional characterization requires a systematic analytical approach that addresses potential sources of discrepancy. The following methodological framework helps reconcile contradictory findings:
Source Identification:
Technical Variation Analysis:
Perform interlaboratory validation studies
Standardize protocols with detailed SOPs
Implement blinded experimental designs and analyses
Biological Variation Assessment:
Evaluate strain-specific differences in VV2132 sequence and expression
Consider growth conditions affecting membrane composition
Assess potential post-translational modifications
Methodological Discrepancy Analysis:
Compare protein preparation techniques (tags, purification methods)
Analyze buffer compositions affecting protein stability
Evaluate assay-specific artifacts or limitations
Resolution Strategies:
Orthogonal Method Validation:
Apply multiple independent techniques to measure the same parameter
Compare results from different experimental approaches
Reconcile findings through cross-validation
Dose-Response and Kinetic Analysis:
Implement comprehensive concentration ranges
Perform time-course experiments to distinguish primary from secondary effects
Apply mathematical modeling to integrate temporal data
Context-Dependent Function Assessment:
Test function under varying environmental conditions
Evaluate potential cooperativity with other proteins
Consider membrane composition effects on protein behavior
Integrative Analysis Approaches:
Meta-Analysis:
Systematically combine data from multiple studies
Weight findings based on methodological robustness
Identify patterns across seemingly contradictory results
Computational Modeling:
Develop models accommodating apparently conflicting observations
Test predictions with targeted experiments
Refine models iteratively with new data
Conditional Functionality Framework:
Establish conditions under which each observed function occurs
Map functional transitions to environmental or cellular changes
Develop integrated model of context-dependent functionality
This comprehensive approach has successfully resolved conflicting data for other bacterial membrane proteins and can be effectively applied to VV2132 characterization. The resolution process may reveal multifunctional properties or context-dependent behaviors that explain apparent contradictions in experimental findings.
Purifying membrane proteins like VV2132 requires specialized approaches to maintain structural integrity while achieving high yields. The following methodological strategy is recommended:
Membrane Extraction Optimization:
Cell Lysis Optimization:
Mechanical disruption (e.g., French press) for efficient membrane release
Buffer optimization (pH 7.5-8.0, ionic strength 150-300 mM)
Protease inhibitor cocktail inclusion to prevent degradation
Detergent Selection:
Systematic screening of detergents (DDM, LMNG, CHAPS) for extraction efficiency
Optimization of detergent concentration (typically 1-2× CMC)
Evaluation of mixed detergent systems for enhanced stability
Chromatographic Purification:
Immobilized Metal Affinity Chromatography (IMAC):
Size Exclusion Chromatography (SEC):
Assessment of oligomeric state and homogeneity
Buffer optimization during SEC
Detection and elimination of aggregates
Quality Control Metrics:
Alternative Approaches:
Native-Like Environment Reconstitution:
Transfer from detergent to nanodiscs or amphipols
Reconstitution into proteoliposomes for functional studies
SMALPs (Styrene Maleic Acid Lipid Particles) for detergent-free extraction
Scale-Up Considerations:
Implement tangential flow filtration for large-scale preparations
Optimize buffer recycling to reduce costs
Develop continuous processing workflows
Storage Optimization:
Maintain in Tris-based buffer with 50% glycerol at -20°C/-80°C
Aliquot to minimize freeze-thaw cycles
Consider lyophilization with cryoprotectants for long-term stability
For VV2132 specifically, current protocols have achieved >90% purity using His-tag affinity chromatography followed by size exclusion chromatography. The purified protein is typically maintained in a Tris-based buffer with glycerol for stability, allowing for successful application in downstream structural and functional studies .
VV2132 belongs to the UPF0208 family of membrane proteins in Vibrio vulnificus, a classification that indicates its function remains uncharacterized. Comparing VV2132 with better-studied Vibrio vulnificus membrane proteins provides valuable context:
Comparative Membrane Protein Analysis:
Structural Comparison:
VV2132 is significantly smaller (150 aa) than major virulence factors like MARTX toxins
Unlike MARTX toxins, which show genetic diversity with four distinct variants arising from genetic recombination , there is no current evidence for similar variation in VV2132
Lacks recognizable effector domains characteristic of toxins like VvhA or MARTX
Functional Implications:
The conserved nature of VV2132 across strains suggests a fundamental rather than pathogen-specific role
Membrane localization indicates potential roles in:
Transport of small molecules
Signal transduction
Membrane organization
Environmental sensing
Evolutionary Context:
While MARTX toxin variants show evidence of recombination with plasmid-carried genes or genes from other species , VV2132 appears more conserved
The smaller size and apparent conservation suggest VV2132 may be under different selective pressures than virulence factors
Understanding these comparative differences is essential for directing experimental approaches to elucidate VV2132 function. While major virulence factors like MARTX and VvhA contribute directly to cytotoxicity and host cell damage , the role of VV2132 may be more subtle, potentially involved in basic cellular processes or environmental adaptation rather than direct virulence mechanisms.
Predicting the function of uncharacterized proteins like VV2132 requires sophisticated bioinformatic approaches that integrate multiple layers of information. The following methodological framework provides a comprehensive prediction strategy:
Sequence-Based Prediction:
Homology Detection:
PSI-BLAST searches against non-redundant protein databases
Profile-HMM searches using HMMER against specialized databases
Remote homology detection using HHpred or PHYRE2
Motif and Domain Analysis:
Scan for conserved domains using InterProScan
Identify functional motifs using PROSITE or PRINTS
Analyze transmembrane topology using TMHMM, TOPCONS
Sequence Property Analysis:
Hydropathy profiling for membrane-spanning regions
Conservation analysis of surface-exposed residues
Disorder prediction to identify flexible regions
Structure-Based Prediction:
Structural Modeling:
Template-based modeling using I-TASSER or SWISS-MODEL
Ab initio modeling for regions lacking templates
Refinement using molecular dynamics simulations
Binding Site Prediction:
CASTp or POCASA for pocket detection
FTSite for ligand binding site prediction
Electrostatic surface analysis for interaction interfaces
Structural Comparisons:
DALI server for structural neighbors identification
TM-align for template-free structural comparisons
ProFunc for function prediction from structure
Network-Based Approaches:
Genomic Context Analysis:
Gene neighborhood conservation across Vibrio species
Co-occurrence patterns with functionally annotated genes
Operonic structure prediction
Protein-Protein Interaction Prediction:
STRING database analysis for interaction partners
Interolog mapping from model organisms
Domain-domain interaction predictions
Integration of -Omics Data:
Correlation analysis with transcriptomic datasets
Co-expression network construction
Integration with available proteomics data
By integrating these complementary approaches, researchers can develop testable hypotheses about VV2132 function. This methodology has successfully predicted functions for other uncharacterized bacterial membrane proteins and provides a systematic framework for characterizing VV2132's role in Vibrio vulnificus biology.
Researchers investigating VV2132 can adapt successful experimental approaches used to characterize other Vibrio vulnificus proteins, particularly VvhA and MARTX toxins. The following methodological framework outlines strategies that can be transferred to VV2132 studies:
Genetic Analysis Approaches:
Targeted Mutagenesis:
Domain Mapping:
Variant Analysis:
Functional Characterization:
Cell-Based Assays:
Host Response Analysis:
In Vivo Models:
Immunological Approaches:
Recombinant Protein Analysis:
Antibody Development:
By adapting these established methodologies that successfully characterized MARTX and VvhA toxins, researchers can systematically investigate VV2132's potential roles in bacterial physiology or pathogenesis. This approach builds on proven techniques while tailoring experiments to the specific characteristics of VV2132 as a membrane protein rather than a secreted toxin.